Messaging Intervention to Increase Medicare Annual Wellness Visits -- The NUDGE AWV Clinical Trial
NCT ID: NCT06640426
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29842 participants
INTERVENTIONAL
2024-10-22
2025-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication
NCT06626321
Evive Health Randomized Controlled Trials
NCT01653197
Promoting Flu Vaccination Through a Mobile Wellness Program
NCT02908893
Using Nudges to Recruit for Health-Related Research
NCT06857903
Effectiveness of a Well-being Web-based Intervention
NCT01586949
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Behavioral science research suggests that personalized messages, designed to facilitate action, can have significant impacts on health behavior. Studies have found these messaging interventions can increase vaccination rates, cancer screening rates, and other care gap closure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
This is a group will serve as usual care and have no intervention during the study period
No interventions assigned to this group
Two Messages
This group will receive two messages as part of the study -- one email and one text message.
Two Messaging Nudges
This intervention involves receiving one personalized email and one personalized text message, which include the provider's name, the patient's name, and a phone number to schedule an Annual Wellness Visit
Up To Five Messages
This group will receive up to five messages as part o the study -- two emails and three text messages.
Five messaging nudges
This intervention involves patients receiving up to five personalized email and text messages, which include the provider's name, the patient's name, and a phone number to schedule an Annual Wellness Visit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Two Messaging Nudges
This intervention involves receiving one personalized email and one personalized text message, which include the provider's name, the patient's name, and a phone number to schedule an Annual Wellness Visit
Five messaging nudges
This intervention involves patients receiving up to five personalized email and text messages, which include the provider's name, the patient's name, and a phone number to schedule an Annual Wellness Visit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have either a mobile phone number or an email address on file with the health system
* Included in and non-compliant on the Ascension AWV Clinical Priority Goal measure
* Have consented to receive electronic communications from the health system
Exclusion Criteria
* Completed MAWV appointment in previous 30 days
* Has an upcoming AWV appointment scheduled
* Have received a nudge campaign from the Clinical Transformation team in the past 90 days
* Patients who have previously opted out of receiving electronic communications from the health system in our message delivery platform (Salesforce)
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emily Rosenzweig
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily Rosenzweig
Director of Behavioral Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ascension Health
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAS20240013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.